380 related articles for article (PubMed ID: 31511392)
1. Type I and Type III Interferons Differ in Their Adjuvant Activities for Influenza Vaccines.
Ye L; Ohnemus A; Ong LC; Gad HH; Hartmann R; Lycke N; Staeheli P
J Virol; 2019 Dec; 93(23):. PubMed ID: 31511392
[TBL] [Abstract][Full Text] [Related]
2. Interferon-λ Improves the Efficacy of Intranasally or Rectally Administered Influenza Subunit Vaccines by a Thymic Stromal Lymphopoietin-Dependent Mechanism.
Ye L; Schnepf D; Ohnemus A; Ong LC; Gad HH; Hartmann R; Lycke N; Staeheli P
Front Immunol; 2021; 12():749325. PubMed ID: 34659250
[TBL] [Abstract][Full Text] [Related]
3. Interferon-λ enhances adaptive mucosal immunity by boosting release of thymic stromal lymphopoietin.
Ye L; Schnepf D; Becker J; Ebert K; Tanriver Y; Bernasconi V; Gad HH; Hartmann R; Lycke N; Staeheli P
Nat Immunol; 2019 May; 20(5):593-601. PubMed ID: 30886417
[TBL] [Abstract][Full Text] [Related]
4. An alphavirus-based adjuvant enhances serum and mucosal antibodies, T cells, and protective immunity to influenza virus in neonatal mice.
Khalil SM; Tonkin DR; Snead AT; Parks GD; Johnston RE; White LJ
J Virol; 2014 Aug; 88(16):9182-96. PubMed ID: 24899195
[TBL] [Abstract][Full Text] [Related]
5. The contribution of type I interferon signaling to immunity induced by alphavirus replicon vaccines.
Thompson JM; Whitmore AC; Staats HF; Johnston R
Vaccine; 2008 Sep; 26(39):4998-5003. PubMed ID: 18656518
[TBL] [Abstract][Full Text] [Related]
6. Immunoglobulin A-deficient mice exhibit altered T helper 1-type immune responses but retain mucosal immunity to influenza virus.
Zhang Y; Pacheco S; Acuna CL; Switzer KC; Wang Y; Gilmore X; Harriman GR; Mbawuike IN
Immunology; 2002 Mar; 105(3):286-94. PubMed ID: 11918690
[TBL] [Abstract][Full Text] [Related]
7. Inactivated Eyedrop Influenza Vaccine Adjuvanted with Poly(I:C) Is Safe and Effective for Inducing Protective Systemic and Mucosal Immunity.
Kim ED; Han SJ; Byun YH; Yoon SC; Choi KS; Seong BL; Seo KY
PLoS One; 2015; 10(9):e0137608. PubMed ID: 26355295
[TBL] [Abstract][Full Text] [Related]
8. Effects of the nature of adjuvant and site of parenteral immunization on the serum and mucosal immune responses induced by a nasal boost with a vaccine alone.
Guy B; Fourage S; Hessler C; Sanchez V; Millet MJ
Clin Diagn Lab Immunol; 1998 Sep; 5(5):732-6. PubMed ID: 9729544
[TBL] [Abstract][Full Text] [Related]
9. Oral Bacteria Combined with an Intranasal Vaccine Protect from Influenza A Virus and SARS-CoV-2 Infection.
Nagai M; Moriyama M; Ichinohe T
mBio; 2021 Aug; 12(4):e0159821. PubMed ID: 34399617
[TBL] [Abstract][Full Text] [Related]
10. A new adjuvanted nanoparticle-based H1N1 influenza vaccine induced antigen-specific local mucosal and systemic immune responses after administration into the lung.
Neuhaus V; Chichester JA; Ebensen T; Schwarz K; Hartman CE; Shoji Y; Guzmán CA; Yusibov V; Sewald K; Braun A
Vaccine; 2014 May; 32(26):3216-22. PubMed ID: 24731807
[TBL] [Abstract][Full Text] [Related]
11. Recombinant H5 hemagglutinin adjuvanted with nanoemulsion protects ferrets against pathogenic avian influenza virus challenge.
Wang SH; Smith D; Cao Z; Chen J; Acosta H; Chichester JA; Yusibov V; Streatfield SJ; Fattom A; Baker JR
Vaccine; 2019 Mar; 37(12):1591-1600. PubMed ID: 30795941
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-1 family cytokines as mucosal vaccine adjuvants for induction of protective immunity against influenza virus.
Kayamuro H; Yoshioka Y; Abe Y; Arita S; Katayama K; Nomura T; Yoshikawa T; Kubota-Koketsu R; Ikuta K; Okamoto S; Mori Y; Kunisawa J; Kiyono H; Itoh N; Nagano K; Kamada H; Tsutsumi Y; Tsunoda S
J Virol; 2010 Dec; 84(24):12703-12. PubMed ID: 20881038
[TBL] [Abstract][Full Text] [Related]
13. Type III interferon exerts thymic stromal lymphopoietin in mediating adaptive antiviral immune response.
Cao L; Qian W; Li W; Ma Z; Xie S
Front Immunol; 2023; 14():1250541. PubMed ID: 37809098
[TBL] [Abstract][Full Text] [Related]
14. Inactivated Influenza Vaccine That Provides Rapid, Innate-Immune-System-Mediated Protection and Subsequent Long-Term Adaptive Immunity.
Chua BY; Wong CY; Mifsud EJ; Edenborough KM; Sekiya T; Tan AC; Mercuri F; Rockman S; Chen W; Turner SJ; Doherty PC; Kelso A; Brown LE; Jackson DC
mBio; 2015 Oct; 6(6):e01024-15. PubMed ID: 26507227
[TBL] [Abstract][Full Text] [Related]
15. Intranasal Immunization with Influenza Virus-Like Particles Containing Membrane-Anchored Cholera Toxin B or Ricin Toxin B Enhances Adaptive Immune Responses and Protection against an Antigenically Distinct Virus.
Ji X; Ren Z; Xu N; Meng L; Yu Z; Feng N; Sang X; Li S; Li Y; Wang T; Zhao Y; Wang H; Zheng X; Jin H; Li N; Yang S; Cao J; Liu W; Gao Y; Xia X
Viruses; 2016 Apr; 8(4):115. PubMed ID: 27110810
[TBL] [Abstract][Full Text] [Related]
16. An α-GalCer analogue with branched acyl chain enhances protective immune responses in a nasal influenza vaccine.
Lee YS; Lee KA; Lee JY; Kang MH; Song YC; Baek DJ; Kim S; Kang CY
Vaccine; 2011 Jan; 29(3):417-25. PubMed ID: 21087689
[TBL] [Abstract][Full Text] [Related]
17. Intranasal administration of a flagellin-adjuvanted inactivated influenza vaccine enhances mucosal immune responses to protect mice against lethal infection.
Hong SH; Byun YH; Nguyen CT; Kim SY; Seong BL; Park S; Woo GJ; Yoon Y; Koh JT; Fujihashi K; Rhee JH; Lee SE
Vaccine; 2012 Jan; 30(2):466-74. PubMed ID: 22051136
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of mucosal adjuvants and immunization routes for the induction of systemic and mucosal humoral immune responses in macaques.
Veazey RS; Siddiqui A; Klein K; Buffa V; Fischetti L; Doyle-Meyers L; King DF; Tregoning JS; Shattock RJ
Hum Vaccin Immunother; 2015; 11(12):2913-22. PubMed ID: 26697975
[TBL] [Abstract][Full Text] [Related]
19. Type I IFN as a vaccine adjuvant for both systemic and mucosal vaccination against influenza virus.
Bracci L; Canini I; Venditti M; Spada M; Puzelli S; Donatelli I; Belardelli F; Proietti E
Vaccine; 2006 Apr; 24 Suppl 2():S2-56-7. PubMed ID: 16823927
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of mucosal and systemic immune responses elicited by GPI-0100- adjuvanted influenza vaccine delivered by different immunization strategies.
Liu H; Patil HP; de Vries-Idema J; Wilschut J; Huckriede A
PLoS One; 2013; 8(7):e69649. PubMed ID: 23936066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
